Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Acute and chronic neurological consequences of early-life Zika virus infection in mice.

Nem de Oliveira Souza I, Frost PS, França JV, Nascimento-Viana JB, Neris RLS, Freitas L, Pinheiro DJLL, Nogueira CO, Neves G, Chimelli L, De Felice FG, Cavalheiro ÉA, Ferreira ST, Assunção-Miranda I, Figueiredo CP, Da Poian AT, Clarke JR.

Sci Transl Med. 2018 Jun 6;10(444). pii: eaar2749. doi: 10.1126/scitranslmed.aar2749.

PMID:
29875203
2.

ADME studies and preliminary safety pharmacology of LDT5, a lead compound for the treatment of benign prostatic hyperplasia.

Noël F, Nascimento-Viana JB, Romeiro LA, Silva RO, Lemes LF, Oliveira AS, Giorno TB, Fernandes PD, Silva CL.

Braz J Med Biol Res. 2016;49(12):e5542. doi: 10.1590/1414-431X20165542.

3.

New Multi-target Antagonists of α1A-, α1D-Adrenoceptors and 5-HT1A Receptors Reduce Human Hyperplastic Prostate Cell Growth and the Increase of Intraurethral Pressure.

Nascimento-Viana JB, Carvalho AR, Nasciutti LE, Alcántara-Hernández R, Chagas-Silva F, Souza PA, Romeiro LA, García-Sáinz JA, Noël F, Silva CL.

J Pharmacol Exp Ther. 2016 Jan;356(1):212-22. doi: 10.1124/jpet.115.227066. Epub 2015 Oct 22.

4.

Pharmacological characterization of N1-(2-methoxyphenyl)-N4-hexylpiperazine as a multi-target antagonist of α1A/α1D-adrenoceptors and 5-HT1A receptors that blocks prostate contraction and cell growth.

Chagas-Silva F, Nascimento-Viana JB, Romeiro LA, Barberato LC, Noël F, Silva CL.

Naunyn Schmiedebergs Arch Pharmacol. 2014 Mar;387(3):225-34. doi: 10.1007/s00210-013-0935-3. Epub 2013 Nov 10.

PMID:
24213881

Supplemental Content

Loading ...
Support Center